Dashboard
Manage Tickers

OMGAOmega Therapeutics, Inc.

Nasdaq omegatherapeutics.com


$ 1.47 $ 0.07 (5.15 %)    

Wednesday, 18-Sep-2024 15:56:30 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 1.43
$ 1.41
$ 1.43 x 100
$ 1.44 x 200
$ 1.38 - $ 1.48
$ 1.22 - $ 6.30
293,124
na
78.87M
$ 1.68
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-06-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 03-10-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 09-10-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

omega-therapeutics-publishes-epigenomic-controller-otx-2002-preclinical-data-in-nature-communications
Omega Therapeutics Publishes Epigenomic Co...
09/17/2024 11:13:06

Treatment with OTX-2002 led to controlled downregulation of MYC gene expression and resulted in significant inhibition of tum...

a-glimpse-into-the-expert-outlook-on-omega-therapeutics-through-4-analysts
A Glimpse Into The Expert Outlook On Omega...
08/15/2024 13:00:13

hc-wainwright--co-reiterates-buy-on-omega-therapeutics-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Omeg...
08/15/2024 11:08:33

HC Wainwright & Co. analyst Robert Burns reiterates Omega Therapeutics (NASDAQ:OMGA) with a Buy and maintains $12 price ...

wedbush-reiterates-outperform-on-omega-therapeutics-maintains-12-price-target
Wedbush Reiterates Outperform on Omega The...
08/07/2024 14:40:34

Wedbush analyst Robert Driscoll reiterates Omega Therapeutics (NASDAQ:OMGA) with a Outperform and maintains $12 price target.

uber-to-rally-over-26-here-are-10-top-analyst-forecasts-for-wednesday
Uber To Rally Over 26%? Here Are 10 Top An...
08/07/2024 12:26:40

chardan-capital-maintains-buy-on-omega-therapeutics-lowers-price-target-to-6
Chardan Capital Maintains Buy on Omega The...
08/07/2024 10:49:20

Chardan Capital analyst Keay Nakae maintains Omega Therapeutics (NASDAQ:OMGA) with a Buy and lowers the price target from $7...

expert-ratings-for-omega-therapeutics
Expert Ratings For Omega Therapeutics
06/18/2024 14:01:12

raymond-james-initiates-coverage-on-omega-therapeutics-with-outperform-rating-announces-price-target-of-12
Raymond James Initiates Coverage On Omega ...
06/18/2024 13:03:49

Raymond James analyst Ryan Deschner initiates coverage on Omega Therapeutics (NASDAQ:OMGA) with a Outperform rating and anno...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
05/13/2024 16:31:04

hc-wainwright--co-reiterates-buy-on-omega-therapeutics-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Omeg...
05/13/2024 10:35:50

HC Wainwright & Co. analyst Robert Burns reiterates Omega Therapeutics (NASDAQ:OMGA) with a Buy and maintains $12 price ...

omega-therapeutics-announced-presentation-of-new-preclinical-data-demonstrating-durable-tunable-bidirectional-regulation-of-gene-expression-in-cellular-models-at-pre-transcriptional-level-at-the-american-society-of-gene-and-cell-therapy-annual-meeting
Omega Therapeutics Announced Presentation ...
05/08/2024 11:13:16

4-analysts-have-this-to-say-about-omega-therapeutics
4 Analysts Have This To Say About Omega Th...
05/07/2024 14:00:29

chardan-capital-maintains-buy-on-omega-therapeutics-maintains-7-price-target
Chardan Capital Maintains Buy on Omega The...
05/07/2024 13:06:37

Chardan Capital analyst Keay Nakae maintains Omega Therapeutics (NASDAQ:OMGA) with a Buy and maintains $7 price target.

omega-therapeutics-q1-2024-gaap-eps-036-misses-035-estimate-sales-2360m-beat-1630m-estimate
Omega Therapeutics Q1 2024 GAAP EPS $(0.36...
05/06/2024 11:09:17

Omega Therapeutics (NASDAQ:OMGA) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of ...

hc-wainwright--co-reiterates-buy-on-omega-therapeutics-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Omeg...
04/30/2024 10:20:03

HC Wainwright & Co. analyst Robert Burns reiterates Omega Therapeutics (NASDAQ:OMGA) with a Buy and maintains $12 price ...

omega-therapeutics-presents-new-preclinical-data-supporting-the-potential-of-precision-epigenomic-control-at-aacr-2024
Omega Therapeutics Presents New Preclinica...
04/09/2024 11:06:40

MYC-directed epigenomic controller exerts anti-tumor effect in preclinical models of EGFR inhibitor-resistant NSCLC regardles...

piper-sandler-reiterates-overweight-on-omega-therapeutics-lowers-price-target-to-9
Piper Sandler Reiterates Overweight on Ome...
04/03/2024 15:27:58

Piper Sandler analyst Edward Tenthoff reiterates Omega Therapeutics (NASDAQ:OMGA) with a Overweight and lowers the price tar...

chardan-capital-maintains-buy-on-omega-therapeutics-lowers-price-target-to-7
Chardan Capital Maintains Buy on Omega The...
04/01/2024 12:24:02

Chardan Capital analyst Keay Nakae maintains Omega Therapeutics (NASDAQ:OMGA) with a Buy and lowers the price target from $1...

omega-therapeutics-q4-2023-gaap-eps-037-beats-047-estimate
Omega Therapeutics Q4 2023 GAAP EPS $(0.37...
03/28/2024 13:18:45

Omega Therapeutics (NASDAQ:OMGA) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(...

how-is-the-market-feeling-about-omega-therapeutics
How Is The Market Feeling About Omega Ther...
01/26/2024 19:45:19

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION